Adverse drug reactions associated with sunitinib therapy: Characteristics and risk factors

Background/Aim. Kidney tumors account for 2–3% of all tumors. Renal cell carcinoma (RCC) is the tenth most common malignancy. Sunitinib is used as the first treatment line in patients with a good and intermediate prognosis. The aim of this study was to analyze the risk factors, frequency, and advers...

書誌詳細
出版年:	Vojnosanitetski Pregled
主要な著者:	Mugoša Snežana, Džamić Zoran, Sahman-Zaimović Majda, Lukovac-Janjić Nevenka
フォーマット:	論文
言語:	英語
出版事項:	Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2021-01-01
主題:	drug-related side effects and adverse reactions kidney neoplasms sunitinib
オンライン･アクセス:	http://www.doiserbia.nb.rs/img/doi/0042-8450/2021/0042-84502000145M.pdf

類似資料

Risk factors for adverse drug reactions associated with clopidogrel therapy
著者:: Mugosa Snezana, 等
出版事項: (2022-04-01)

Uncommon Side Effects of Sunitinib Therapy in a Patient with Metastatic Renal Cell Cancer: Case Report
著者:: Robert Šeparović, 等
出版事項: (2018-01-01)

Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
著者:: Xinzhen Che, 等
出版事項: (2025-06-01)

Correction: Gastrointestinal stromal tumors with the use of ripretinib and sunitinib: real-world adverse event analysis based on the FDA adverse event reporting system (FAERS)
著者:: Xinzhen Che, 等
出版事項: (2025-09-01)

The Utility of the Liverpool Adverse Drug Reaction Assessment Tools in the Evaluation of Chemotherapy-Induced Nausea and Vomiting in Children
著者:: Elisangela Costa Lima, 等
出版事項: (2023-07-01)

A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for sunitinib
著者:: Xusheng Zhang, 等
出版事項: (2024-07-01)

Sunitinib resistance in renal cell carcinoma
著者:: Christudas Morais
出版事項: (2014-04-01)

PHARMACOEPIDEMIOLOGICAL STUDIES OF ADVERSE REACTIONS OF DEVELOPED DRUGS
著者:: E. J. Kolesnikova
出版事項: (2022-06-01)

Case report of a renal cell carcinoma patient with acute pancreatitis under both sunitinib and axitinib treatment
著者:: Utku Oflazoglu, 等
出版事項: (2016-08-01)

Risk factors associated with adverse reactions to antituberculosis drugs
著者:: Laíse Soares Oliveira Resende, 等
出版事項: (2015-02-01)

Pharmacovigilance as an imperative of modern medicine - experience from Montenegro
著者:: Mugoša Snežana, 等
出版事項: (2017-01-01)

Spontaneous adverse drug reaction reporting by community pharmacists: preparedness and barriers
著者:: Mohamed Bahlol, 等
出版事項: (2022-07-01)

Pharmacovigilance: Empowering healthcare professionals
著者:: Mugoša Snežana S., 等
出版事項: (2015-01-01)

Prevalence and Management of Immediate Adverse Reactions to Chemotherapy in Breast Cancer Patients: A Retrospective Study
著者:: Guillermo Insfran, 等
出版事項: (2025-01-01)

Effectiveness of mobile applications in enhancing adverse drug reaction reporting: a systematic review
著者:: Liyanage PH, 等
出版事項: (2025-05-01)

Adverse drug reactions reported over 5 years in a regional university hospital
著者:: Jaechun Lee, 等
出版事項: (2024-09-01)

The Efficacy of Sunitinib Treatment of Renal Cancer Cells Is Associated with the Protein PHAX In Vitro
著者:: Rafia S. Al-Lamki, 等
出版事項: (2020-04-01)

Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
著者:: Yoshiki Murase, 等
出版事項: (2021-09-01)

Adverse Drug Reactions Among Hospitalized Psychiatric Patients, Prevalence, Severity, Preventability, and Opportunities for Intervention
著者:: Asma Al Hindi, 等
出版事項: (2024-05-01)

Are we PREPAREd? Concerning the “PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study”
著者:: Ana de Carmo Campos, 等
出版事項: (2023-10-01)

Potential for use sunitinib in pancreatic neuroendocrine tumors
著者:: A. A. Markovich, 等
出版事項: (2019-06-01)

Erosive nappy erythema following sunitinib intake
著者:: Saoussane Kharmoum, 等
出版事項: (2013-02-01)

Spontaneous Adverse Drug Reaction Reporting of Congenital Malformations: A Danish National Register Study
著者:: Ulrik Lausten-Thomsen, 等
出版事項: (2025-06-01)

Biological Role of Pazopanib and Sunitinib Aldehyde Derivatives in Drug-Induced Liver Injury
著者:: Maud Maillard, 等
出版事項: (2022-09-01)

Adverse drug reactions following treatment of latent tuberculosis infection: a linked national tuberculosis surveillance with claims database
著者:: Yu-Seon Jung, 等
出版事項: (2024-11-01)

A systematic review of observational studies evaluating costs of adverse drug reactions
著者:: Batel Marques F, 等
出版事項: (2016-08-01)

Sins and Risks in Underreporting Suspected Adverse Drug Reactions
著者:: Austin Due
出版事項: (2024-05-01)

Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: Report of a case and literature review of kinase inhibitors and blocking antibodies
著者:: Shuchi Bansal, 等
出版事項: (2014-01-01)

Combined Ibuprofen-Nanoconjugate Micelles with E-Selectin for Effective Sunitinib Anticancer Therapy
著者:: Zeng X, 等
出版事項: (2022-12-01)

A significant response to sunitinib in a patient with anaplastic thyroid carcinoma
著者:: Enrique Grande, 等
出版事項: (2013-01-01)

Immune checkpoint inhibitors⁃related nervous system adverse events
著者:: WANG Ze⁃yi, 等
出版事項: (2022-09-01)

Mortality and years of life lost related to adverse drug events in Brazil
著者:: Lunara Teles Silva, 等
出版事項: (2024-05-01)

Reports of Symptoms Associated with Supraventricular Arrhythmias as a Serious Adverse Drug Reaction in the Spanish Pharmacovigilance Database
著者:: Javier Pueyo-Val, 等
出版事項: (2023-08-01)

Adverse events associated with donor plateletpheresis: A 10-year experience from Vojvodina, Serbia
著者:: Budakov-Obradović Zorana, 等
出版事項: (2022-01-01)

Acyclovir‐induced psychiatric and renal adverse effects in a diabetic patient: A case report
著者:: Soheil Roshanzamiri, 等
出版事項: (2024-08-01)

Adverse Drug Reactions of Cardiovascular Classes of Medicines—Data for Bulgarian Population
著者:: Zornitsa Mitkova, 等
出版事項: (2024-09-01)

Comparison of the Completeness of Spontaneously Reported Adverse Drug Reactions by Consumers, Healthcare Professionals, and Pharmaceutical Companies: An Evaluation of Databases From Two High‐Income Countries
著者:: Mohammed Gebre Dedefo, 等
出版事項: (2025-08-01)

The yin yang of sunitinib: One drug, two doses, and multiple outcomes
著者:: Mohamed Elgendy
出版事項: (2017-03-01)

Evaluation of Interstitial Lung Disease Complications Caused by Biologic Agents Using a Spontaneous Adverse Drug Reaction Reporting Database
著者:: Ayu Minagi, 等
出版事項: (2025-04-01)

Soluble KIT correlates with clinical outcome in patients with metastatic breast cancer treated with sunitinib
著者:: Keyvanjah Kiana, 等
出版事項: (2012-08-01)